secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0000950170-24-022604
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix secures 10-year US government contract; Medicare coverage decision pending
--------------------------------------------------------------------------------

- KidneyIntelX.dkd added to 10-year GWAC through GSA, covering VA, DoD, IHS, at $950/result.
- NGS holds Open Public Meeting on proposed coverage policy DL39726; final LCD expected FY2024.
- Effective Jan 1, 2024, test priced at $950 on CMS CLFS for three years.
- These advancements expected to enable insurance coverage for 10M of 14M FDA-indicated patients.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024022604/0000950170-24-022604-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024022604/rnlx-20240229.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-022604

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer